about
Selected life-extending interventions reduce arterial CXCL10 and macrophage colony-stimulating factor in aged mouse arteries.GM-CSF primes cardiac inflammation in a mouse model of Kawasaki disease.A xenograft model of macrophage activation syndrome amenable to anti-CD33 and anti-IL-6R treatment.Granulocyte macrophage colony-stimulating factor receptor α expression and its targeting in antigen-induced arthritis and inflammationMaking sense of the cause of Crohn's - a new look at an old disease.Multifaceted role of IL-21 in rheumatoid arthritis: Current understanding and future perspectives.Slc11a1 (Nramp-1) gene modulates immune-inflammation genes in macrophages during pristane-induced arthritis in mice.Selected cytokine pathways in rheumatoid arthritis.MiRNA-Mediated Macrophage Polarization and its Potential Role in the Regulation of Inflammatory Response.Myeloid but not epithelial tissue factor exerts protective anti-inflammatory effects in acid aspiration-induced acute lung injuryMolecular mechanisms regulating secretory organelles and endosomes in neutrophils and their implications for inflammation.Novel GM-CSF-based vaccines: One small step in GM-CSF gene optimization, one giant leap for human vaccines.On the origin of myeloid-derived suppressor cells.Ex-Th17 (Nonclassical Th1) Cells Are Functionally Distinct from Classical Th1 and Th17 Cells and Are Not Constrained by Regulatory T Cells.Spotlight on mavrilimumab for the treatment of rheumatoid arthritis: evidence to dateCCR6+ Th cells in the cerebrospinal fluid of persons with multiple sclerosis are dominated by pathogenic non-classic Th1 cells and GM-CSF-only-secreting Th cells.Cytokine amplification and macrophage effector functions in aortic inflammation and abdominal aortic aneurysm formation.The MHC class II antigen presentation pathway in human monocytes differs by subset and is regulated by cytokines.Ebola Virus Binding to Tim-1 on T Lymphocytes Induces a Cytokine Storm.Rheumatology around the world: perspectives from Australia and New Zealand.Alteration of the intestinal microbiome characterizes preclinical inflammatory arthritis in mice and its modulation attenuates established arthritis.Biodistribution and Immunogenicity of Allogeneic Mesenchymal Stem Cells in a Rat Model of Intraarticular Chondrocyte Xenotransplantation.T Cell Production of GM-CSF Protects the Host during Experimental Tuberculosis.Pharmacokinetics, Pharmacodynamics, and Proposed Dosing of the Oral JAK1 and JAK2 Inhibitor Baricitinib in Pediatric and Young Adult CANDLE and SAVI Patients.Central inhibition of granulocyte-macrophage colony-stimulating factor is analgesic in experimental neuropathic pain.The infarcted myocardium solicits GM-CSF for the detrimental oversupply of inflammatory leukocytes.Dissecting human ILC heterogeneity: more than just three subsets.Investigational therapies targeting the granulocyte macrophage colony-stimulating factor receptor-α in rheumatoid arthritis: focus on mavrilimumab.BATF-dependent IL-7RhiGM-CSF+ T cells control intestinal graft-versus-host disease.The Activin A-Peroxisome Proliferator-Activated Receptor Gamma Axis Contributes to the Transcriptome of GM-CSF-Conditioned Human Macrophages.Methotrexate limits inflammation through an A20-dependent cross-tolerance mechanism.Cytokine mediators of chronic graft-versus-host disease.TNF and granulocyte macrophage-colony stimulating factor interdependence mediates inflammation via CCL17.Peripheral alveolar nitric oxide concentration reflects alveolar inflammation in autoimmune pulmonary alveolar proteinosis.Mucosal-Associated Invariant T Cells Are Depleted and Exhibit Altered Chemokine Receptor Expression and Elevated Granulocyte Macrophage-Colony Stimulating Factor Production During End-Stage Renal Disease.Redox-Mediated Mechanisms Fuel Monocyte Responses to CXCL12/HMGB1 in Active Rheumatoid ArthritisTofacitinib inhibits granulocyte-macrophage colony-stimulating factor-induced NLRP3 inflammasome activation in human neutrophilsGM-CSF Quantity Has a Selective Effect on Granulocytic vs. Monocytic Myeloid Development and Function
P2860
Q36340801-E4E87A45-195F-4F0F-9769-E11285AC1E01Q37272083-4325346E-1D5B-4D32-BB0E-CE10E1E15B6AQ37277020-8D733FD0-594C-418C-99A7-4A179638180BQ37466119-99ED56D0-179E-4767-A4AC-49774760D9AEQ37577712-61204BB4-F84E-4005-9F34-4A70C0DD5C0EQ38638262-760B4425-6024-434A-9EF6-62A523219C88Q38698195-993123E7-349F-440B-B94F-F1DC9CBE3C6AQ38755912-0F366845-57CE-4FA2-A87B-270F087ED5B3Q38765627-25E4A88B-C5DD-4BAA-846F-E0F2BACC4C23Q38783481-11E30EDF-1945-410A-AF84-23F96E384305Q38936540-7ACC8B83-C9FD-4DC4-98F2-348E59A8FCCDQ38936958-6A08380D-6CC6-4A22-8B33-0A4D7246E541Q38968944-59CEE7B9-5437-41E3-A577-7977C2B210B7Q38975415-3A477207-C867-4EB6-ADB5-0752A5677379Q38988087-6BB14A89-8641-4AFC-8D70-19E77C0053D0Q41005423-609FD2F0-C7B9-48C7-858B-E44DCA0A0E29Q41114435-241C3E22-E60F-4F3E-BF20-33EB9F795DE6Q41497268-B7933CF2-A8BF-4B67-AECB-C310055FD630Q41676229-C96D6C07-831F-4404-9CEB-F352412AF624Q42322540-57891E63-E55E-496C-B02E-A5B760A8CDDBQ47108321-2E66616B-1100-4B8C-83A1-B45C50DBC73AQ47123674-FAC2BE6F-CD25-4A07-91CE-CD387497A967Q47152562-5F859E75-27CD-4CC9-9F7A-595F557C6F56Q47602482-6157E120-EEAA-4C6C-B26D-047F189F43E3Q47652745-F734E462-31CF-4050-892D-B703F11855F4Q47696973-D8183385-E73B-40C8-AA86-573BBE90914EQ48300283-DCF501FB-BC6A-4EEE-839A-1249EADF0980Q49393096-E0539E93-2F07-468A-8959-1EBC2F300DC0Q49613332-970FAA74-8A8F-4057-9824-64D0999BA462Q49779441-A5A269D6-D28A-4FAC-91A3-0593706C4950Q50047899-3C17DB99-6E83-43FF-87BA-2F4AA9988116Q50915048-308C8988-1009-47A3-94FA-516921EFFD1FQ52644010-F353D396-FB38-4DD0-992B-9667647757FEQ54960585-655887B5-FF5A-47C9-9E49-E0864CA5F34CQ54963446-CEBA8EFF-87A9-4798-9050-E9C12F0B6C8EQ57072691-27B46850-A834-43E4-88C4-CD318799B530Q58694864-41FCDA3D-7256-4BDA-9E72-7061138B666AQ58698466-C8C14344-201D-465C-BC86-CEDEC765FD89
P2860
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Targeting GM-CSF in inflammatory diseases.
@en
type
label
Targeting GM-CSF in inflammatory diseases.
@en
prefLabel
Targeting GM-CSF in inflammatory diseases.
@en
P2860
P356
P1476
Targeting GM-CSF in inflammatory diseases.
@en
P2093
Ian P Wicks
P2860
P2888
P356
10.1038/NRRHEUM.2015.161
P407
P577
2015-12-03T00:00:00Z
P6179
1040165780